Release 4B Snapshot #1

This page is part of the FHIR Specification (v4.3.0-snapshot1: Release 4B Snapshot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Activitydefinition-medicationorder-example

Clinical Decision Support Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Not linked to any defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ActivityDefinition.


Generated Narrative

Resource "citalopramPrescription"

url: http://motivemi.com/artifacts/ActivityDefinition/citalopramPrescription

identifier: id: citalopramPrescription (OFFICIAL)

version: 1.0.0

name: CitalopramPrescription

title: Citalopram Prescription

status: active

experimental: true

date: 2015-08-15

publisher: Motive Medical Intelligence

contact: ph: 415-362-4007(WORK),info@motivemi.com

description: Citalopram 20 mg tablet 1 tablet oral 1 time daily now (30 table; 3 refills

jurisdiction: United States of America (unknown#US)

purpose: Defines a guideline supported prescription for the treatment of depressive disorders

usage: This activity definition is used as part of various suicide risk order sets

copyright: © Copyright 2016 Motive Medical Intelligence. All rights reserved.

approvalDate: 2016-03-12

lastReviewDate: 2016-08-15

effectivePeriod: 2016-01-01 --> 2017-12-31

topic: Mental Health Treatment ()

author: Motive Medical Intelligence: ph: 415-362-4007(WORK),info@motivemi.com

kind: MedicationRequest

product:

Resource "citalopramMedication"

code: citalopram (RxNorm#200371)

form: Tablet dose form (SNOMED CT#385055001)

Ingredients

-Item[x]
*#citalopramSubstance

dynamicValue

path: dispenseRequest.numberOfRepeatsAllowed

dynamicValue

path: dispenseRequest.quantity


 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.